Ranibizumab and Bevacizumab for Neovascular Age-Related Macular Degeneration

The CATT Research Group·2011·New England Journal of Medicine

DOI 10.1056/nejmoa1102673

Cited by (1,009)

Items 901–1,000 of 1,009

Association of Anti-VEGF Injections with Progression of Geographic Atrophy
Ryan Enslow, Sai Bhuvanagiri, Sravanthi Vegunta, Benjamin Cutler, Michael Neff, Brian C. Stagg · 2016 · Ophthalmology and Eye Diseases
Simultaneous multimodal ophthalmic imaging using swept-source spectrally encoded scanning laser ophthalmoscopy and optical coherence tomography
Joseph D. Malone, Mohamed T. El‐Haddad, Ivan Bozic, Logan A. Tye, Lucas Majeau, Nicolas Godbout, Andrew M. Rollins, Caroline Boudoux, Karen M. Joos, Shriji N. Patel et al. · 2016 · Biomedical Optics Express
Characteristics of patients with neovascular age-related macular degeneration who are non-responders to intravitreal aflibercept
Chikako Hara, Taku Wakabayashi, Hiroshi Toyama, Yoko Fukushima, Kaori Sayanagi, Shigeru Sato, Hirokazu Sakaguchi, Kohji Nishida · 2018 · British Journal of Ophthalmology
Five-Year Follow-up of Nonfibrotic Scars in the Comparison of Age-Related Macular Degeneration Treatments Trials
Ebenezer Daniel, Gui‐Shuang Ying, Benjamin J. Kim, Cynthia Ann Toth, Frederick L. Ferris, Daniel Francis Martin, Juan E. Grunwald, Glenn J. Jaffe, Joshua L. Dunaief, Wei Pan et al. · 2018 · Ophthalmology
Repeat Corneal Neovascularization is Characterized by More Aggressive Inflammation and Vessel Invasion Than in the Initial Phase
Anthony Mukwaya, Pierfrancesco Mirabelli, Anton Lennikov, Muthukumar Thangavelu, Lasse D. Jensen, Beatrice Bourghardt Peebo, Neil Lagali · 2019 · Investigative Ophthalmology & Visual Science
Surgical management of submacular hemorrhage due to n-AMD: a comparison of three surgical methods
Carsten Grohmann, Spyridon Dimopoulos, Karl Ulrich Bartz‐Schmidt, Philipp Schindler, Toam R. Katz, Martin S. Spitzer, Christos Skevas · 2020 · International Journal of Retina and Vitreous
CONSEQUENCES OF LAPSES IN TREATMENT WITH VASCULAR ENDOTHELIAL GROWTH FACTOR INHIBITORS IN NEOVASCULAR AGE-RELATED MACULAR DEGENERATION IN ROUTINE CLINICAL PRACTICE
Tyler E. Greenlee, Victoria Y. Wang, Hannah Kang, Marc E. Ohlhausen, Andrew X. Chen, Grant L. Hom, Thais F. Conti, Isaac N. Briskin, Amy S Babiuch, Rishi P. Singh · 2020 · Retina
A Cost-Benefit Analysis of VEGF-Inhibitor Therapy for Neovascular Age-Related Macular Degeneration in the United States
Gary C. Brown, Melissa M. Brown, Sara B. Rapuano, David S. Boyer · 2020 · American Journal of Ophthalmology
Targeting vascular endothelial growth factor using retinal gene therapy
Sook Hyun Chung, Sonia L. Frick, Glenn C. Yiu · 2021 · Annals of Translational Medicine
Feasibility of peripheral OCT imaging using a novel integrated SLO ultra-widefield imaging swept-source OCT device
Simrat K. Sodhi, John Golding, Carmelina Trimboli, Netan Choudhry · 2021 · International Ophthalmology
Biomarkers as Predictive Factors of Anti-VEGF Response
Miriam Bobadilla, Ana Pariente, Ana I., Rafael Peláez, Álvaro Pérez-Sala, Ignacio M. Larráyoz · 2022 · Biomedicines
Protein and polypeptide mediated delivery to the eye
Sara Aly Attia, John Andrew MacKay · 2022 · Advanced Drug Delivery Reviews
Ranibizumab for the treatment of degenerative ocular conditions
Georgios D. Panos, Magdalini Triantafylla, Horace F. Massa, Doukas Dardabounis, Zisis Gatzioufas, Vassilios Kozobolis, Konstantinos Ioannakis, İrfan Perente · 2014 · Clinical ophthalmology
Evaluation of cytotoxicity of bevacizumab on VEGF-enriched corneal endothelial cells.
Raluca Rusovici, Monali V. Sakhalkar, Kakarla V Chalam · 2011 · Europe PMC (PubMed Central)
The Expanding Role of Therapeutic Antibodies
Simonetta Salemi, Milica Marković, Gabriella Martini, Raffaele D’Amelio · 2014 · International Reviews of Immunology
ELLIPSOID ZONE MAPPING AND OUTER RETINAL CHARACTERIZATION AFTER INTRAVITREAL OCRIPLASMIN
Yuji Itoh, Justis P. Ehlers · 2016 · Retina
Recommended Guidelines for Use of Intravitreal Aflibercept With a Treat-and-Extend Regimen for the Management of Neovascular Age-Related Macular Degeneration in the Asia-Pacific Region: Report From a Consensus Panel
Adrian Koh, Paolo Lanzetta, Won Ki Lee, Chi‐Chun Lai, Wai‐Man Chan, Chung‐May Yang, Chui Ming Gemmy Cheung · 2017 · Asia-Pacific Journal of Ophthalmology
Intravitreal Aflibercept Versus Ranibizumab for Wet Age-Related Macular Degeneration: A Cost-Effectiveness Analysis
Luis Hernandez, Tereza Lanitis, Clifford Cele, Hector Toro‐Díaz, Andrea Gibson, Andreas Kuznik · 2018 · Journal of Managed Care & Specialty Pharmacy
Negative regulators of angiogenesis, ocular vascular homeostasis, and pathogenesis and treatment of exudative AMD
Nader Sheibani, Mitra Farnoodian, Christine M. Sorenson · 2018 · Journal of Ophthalmic and Vision Research
Biosimilars of anti-vascular endothelial growth factor for ophthalmic diseases: A review
Neil M. Bressler, Peter K. Kaiser, V. Diana, Quan Dong Nguyen, Kyu Hyung Park, Se Joon Woo, Min Sagong, Mario Bradvica, Mercy Yeeun Kim, Seungkee Kim et al. · 2024 · Survey of Ophthalmology
VITREOMACULAR TRACTION AFFECTS ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR TREATMENT OUTCOMES FOR EXUDATIVE AGE-RELATED MACULAR DEGENERATION
Radhika Krishnan, Rashi Arora, Gabriella De Salvo, Alina Stinghe, Philip S. Severn, Bishwanath Pal, Srinivas V. Goverdhan · 2015 · Retina
Intravitreal bevacizumab monotherapy for retinopathy of prematurity
Alparslan Şahin, Muhammed Şahin, Abdullah Kürşat Cingü, Yasin Çınar, Fatih Mehmet Türkçü, Harun Yüksel, Savaş Kaya, Şeyhmus Arı, İhsan Çaça · 2013 · Pediatrics International
Intravitreal dexamethasone implant versus anti-VEGF injection for treatment-naïve patients with retinal vein occlusion and macular edema: a 12-month follow-up study
Christophe Chiquet, C. Dupuy, Alain Marie Bron, Florent Aptel, Morgane Straub, Rodica Isaïco, Jean Paul Romanet, Catherine P Creuzot-Garcher · 2015 · Graefe s Archive for Clinical and Experimental Ophthalmology
PENETRATION OF BEVACIZUMAB AND RANIBIZUMAB THROUGH RETINAL PIGMENT EPITHELIAL LAYER IN VITRO
Hiroto Terasaki, Taiji Sakamoto, Makoto Shirasawa, Naoya Yoshihara, Hiroki Otsuka, Shozo Sonoda, Toshio Hisatomi, Tatsuro Ishibashi · 2015 · Retina
Comparison of bevacizumab and ranibizumab in age-related macular degeneration: a systematic review and meta-analysis.
Xiaoyu Zhang, Xiaofan Guo, Shaodan Zhang, Jing-Na He, Caoyu Sun, Yin Zou, Han-Si Bi, Yang Qu · 2014 · Europe PMC (PubMed Central)
Treatment of age-related macular degeneration
Chui Ming Gemmy Cheung, Tien Yin Wong · 2013 · The Lancet
Single- and repeated-dose toxicity study of bevacizumab, ranibizumab, and aflibercept in ARPE-19 cells under normal and oxidative stress conditions
Manuel Sáenz-de-Viteri, Patricia Fernández‐Robredo, María Hernández, Jaione Bezunartea, Nicholas Reiter, Sergio Recalde, Alfredo García‐Layana · 2016 · Biochemical Pharmacology
AFLIBERCEPT FOR THE TREATMENT OF RETINAL PIGMENT EPITHELIAL DETACHMENTS
Lingmin He, Ruwan Amila Silva, Darius M. Moshfeghi, Mark Scott Blumenkranz, Theodore Leng · 2015 · Retina
The past, present and future management of sickle cell retinopathy within an African context
Kwesi Nyan Amissah-Arthur, Evelyn Mensah · 2018 · Eye
Predominantly Persistent Subretinal Fluid in the Comparison of Age-Related Macular Degeneration Treatments Trials
Jason Q. Core, Maxwell Pistilli, Ebenezer Daniel, Juan E. Grunwald, Cynthia Ann Toth, Glenn J. Jaffe, Peiying Hua, Daniel Francis Martin, Gui‐Shuang Ying, Maureen G. Maguire · 2021 · Ophthalmology Retina
The Biosimilar Paradox
Casey Zhang, Scott M. Friedman, Prithvi Mruthyunjaya, Ravi Parikh · 2023 · Ophthalmology
Suggestive association between PLA2G12A single nucleotide polymorphism rs2285714 and response to anti-vascular endothelial growth factor therapy in patients with exudative age-related macular degeneration.
Vinson M. Wang, Richard B. Rosen, CATHERINE B. MEYERLE, Shree K. Kurup, Daniel Ardeljan, Elvira Agrón, Katy W. Tai, Matthew Pomykala, Emily Y. Chew, Chi‐Chao Chan et al. · 2012 · Europe PMC (PubMed Central)
Intravitreal steroid and anti-vascular endothelial growth agents for the management of retinal vein occlusion: evidence from randomized trials
Irini Chatziralli, Luke Nicholson, Sobha Sivaprasad, Philip G. Hykin · 2015 · Expert Opinion on Biological Therapy
Comparative study of 1+PRN ranibizumab versus bevacizumab in the clinical setting
Falcão, Carneiro, Mendonça, Sofia L. Fonseca, Brandão, Fernando Falcão‐Reis · 2012 · Clinical ophthalmology
Suppression of Choroidal Neovascularization Through Inhibition of APE1/Ref-1 Redox Activity
Yue Li, Xiuli Liu, Tongrong Zhou, Mark R. Kelley, Paul Andrew Edwards, Hua Gao, Xiaoxi Qiao · 2014 · Investigative Ophthalmology & Visual Science
Immunotherapeutic Applications of IL-18
Hiroko Tsutsui, Kenji Nakanishi · 2012 · Immunotherapy
Pre-Analytical Parameters Affecting Vascular Endothelial Growth Factor Measurement in Plasma: Identifying Confounders
Johanna M. Pfeil, Daniel Böhringer, Heidrun L. Deissler, L. Faerber, Jens C. Goepfert, Peter Heiduschka, Susannah M. Kleeberger, Alexa Klettner, Tim U. Krohne, Nicole Schneiderhan‐Marra et al. · 2016 · PLoS ONE
Optical Coherence Tomography-based Diagnosis of Polypoidal Choroidal Vasculopathy in Korean Patients
Young Suk Chang, Jae Hui Kim, Jong Woo Kim, Tae Gon Lee, Chul Gu Kim · 2016 · Korean Journal of Ophthalmology
Hypoxia‐induced vascular endothelial growth factor secretion by retinal pigment epithelial cells is inhibited by melatonin via decreased accumulation of hypoxia‐inducible factors‐1α protein
Yu‐Hung Lai, Dan‐Ning Hu, Richard B. Rosen, Jodi Sassoon, Lea‐Yea Chuang, Kwou‐Yeung Wu, Wen‐Chuan Wu · 2016 · Clinical and Experimental Ophthalmology
Licence to save: a UK survey of anti-VEGF use for the eye in 2015
Ahmed K. Shalaby, Karinya Lewis, Kate Bush, Paul R. Meredith, Sandro Di Simplicio, Alastair Lockwood · 2016 · Eye
Modern Therapeutic Approaches for Noninfectious Ocular Diseases Involving Inflammation
Michelle L. Ratay, Elena Bellotti, Riccardo Gottardi, Steven R. Little · 2017 · Advanced Healthcare Materials
Outcomes of Cataract Surgery in Patients With Exudative Age-related Macular Degeneration and Macular Fluid
Matthew R. Starr, Michael A. Mahr, Andrew J. Barkmeier, Raymond Iezzi, Wendy M. Smith, Sophie J. Bakri · 2018 · American Journal of Ophthalmology
Long‐term therapeutic effect in nonhuman primate eye from a single injection of anti‐VEGF controlled release hydrogel
Yu Yu, Xingyan Lin, Qilin Wang, Mingguang He, Ying Chau · 2019 · Bioengineering & Translational Medicine
Thermo-responsive hydrogel as an anti-VEGF drug delivery system to inhibit retinal angiogenesis in Rex rabbits
Chao-Chien Hu, Yin‐Chen Chiu, Jen-Ray Chaw, Chin-Fu Chen, Hsia‐Wei Liu · 2019 · Technology and Health Care
Revascularization after angiogenesis inhibition favors new sprouting over abandoned vessel reuse
Anthony Mukwaya, Pierfrancesco Mirabelli, Anton Lennikov, Muthukumar Thangavelu, Maria P. Ntzouni, Lasse D. Jensen, Beatrice Bourghardt Peebo, Neil Lagali · 2019 · Angiogenesis
Twenty-four-month outcomes of inflammatory choroidal neovascularisation treated with intravitreal anti-vascular endothelial growth factors: a comparison between two treatment regimens
Alessandro Invernizzi, Francesco Pichi, Richard J. Symes, Sophia L. Zagora, Aniruddha Kishandutt Agarwal, Vuong Nguyen, Stefano Erba, Alba Xhepa, Luca De Simone, Luca Cimino et al. · 2019 · British Journal of Ophthalmology
Functional, structural, and molecular identification of lymphatic outflow from subconjunctival blebs
Goichi Akiyama, Sindhu Saraswathy, Thania Bogarin, Xiaojing Pan, Ernesto Barrón, Tina Tzee Ling Wong, Mika Kato Kaneko, Yukinari Kato, Young Kwon Hong, Alex S. Huang · 2020 · Experimental Eye Research
Individualized Therapy with Ranibizumab in Wet Age-Related Macular Degeneration
Alfredo García‐Layana, Marta S. Figueroa, Luís Arias, Javier Araiz, José M. Ruiz‐Moreno, José García‐Arumí, Francisco Gómez‐Ulla, María Isabel López Gálvez, Francisco Antonio Cabrera López, Jose Manuel García-Campos et al. · 2015 · Journal of Ophthalmology
Retinoblastoma: direct chemotherapeutic drug delivery into the vitreous cavity
Stefan Seregard, Arun D. Singh · 2012 · British Journal of Ophthalmology
Ranibizumab and Bevacizumab for AMD
Chui Ming Gemmy Cheung, Tien Yin Wong · 2011 · New England Journal of Medicine
INFLUENCE OF VITREOMACULAR INTERFACE ON ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY USING TREAT AND EXTEND TREATMENT PROTOCOL FOR AGE-RELATED MACULAR DEGENERATION (VINTREX)
Samuel K Steven Houston, Nadim Rayess, Michael N. Cohen, Allen C. Ho, Carl D. Regillo · 2015 · Retina
Visual acuity outcomes of anti-VEGF treatment for neovascular age-related macular degeneration in clinical trials
Kenji Yamashiro, Akio Oishi, Masayuki Hata, Ayako Takahashi, Akitaka Tsujikawa · 2021 · Japanese Journal of Ophthalmology
Intravitreal anti-vascular endothelial growth factor monotherapy for large submacular hemorrhage secondary to neovascular age-related macular degeneration
H S Kim, H J Cho, Seul Gi Yoo, J H Kim, Jung Il Han, T G Lee, J W Kim · 2015 · Eye
Measures of biosimilarity in monoclonal antibodies in oncology: the case of bevacizumab
Hans C. Ebbers, Peter J.K. van Meer, Ellen H.M. Moors, Aukje Kaija Mantel-Teeuwisse, Hubert G. M. Leufkens, Huub Schellekens · 2013 · Drug Discovery Today
THE EFFECTS OF AFLIBERCEPT ON THE VIABILITY AND METABOLISM OF OCULAR CELLS IN VITRO
David A. Ammar, Naresh Mandava, Malik Y. Kahook · 2012 · Retina
Beta‐lapachone inhibits pathological retinal neovascularization in oxygen‐induced retinopathy via regulation of HIF ‐1α
Sung Wook Park, Jin Hyoung Kim, Ko‐Eun Kim, Moon Hee Jeong, Hyunsung Park, Bongju Park, Young‐Ger Suh, Woo Jin Park, Jeong Hun Kim · 2014 · Journal of Cellular and Molecular Medicine
Emerging roles for antiangiogenesis factors in management of ocular disease
Muhammad Usman Saeed, Gkaragkani, Ali · 2013 · Clinical ophthalmology
Insulin-Like Growth Factor-1 and Anti-Vascular Endothelial Growth Factor in Retinopathy of Prematurity: Has the Time Come
Andreas Stahl, Ann Hellström, Lois E. H. Smith · 2014 · Neonatology
NEAR VISION OUTCOME IN PATIENTS WITH AGE-RELATED MACULAR DEGENERATION TREATED WITH AFLIBERCEPT
David Lee Epstein, Urban Amrén · 2016 · Retina
Prospective Study of Vessel Density by Optical Coherence Tomography Angiography After Intravitreal Bevacizumab in Exudative Age-Related Macular Degeneration
Gilda Cennamo, Daniela Montorio, Anna D’Alessandro, Pasquale Napolitano, Luca D’Andrea, Fausto Tranfa · 2019 · Ophthalmology and Therapy
Hyperreflective foci in predicting the treatment outcome of antivascular endothelial growth factor in neovascular age-related macular degeneration
Yun Hsia, Chang‐Hao Yang, Yi‐Ting Hsieh, Chung‐May Yang, Tzyy‐Chang Ho, Tso‐Ting Lai · 2019 · Graefe s Archive for Clinical and Experimental Ophthalmology
Patient Preferences for Anti-Vascular Endothelial Growth Factor Treatment for Wet Age-Related Macular Degeneration in Japan: A Discrete Choice Experiment
Takeshi Joko, Yoshimi Nagai, Ryusaburo Mori, Koji Tanaka, Yuji Oshima, Yusuke Hikichi, Tetsushi Komori, João Carrasco, Martine C. Maculaitis, Oliver Will et al. · 2020 · Patient Preference and Adherence
Localized Optical Coherence Tomography Precursors of Macular Atrophy and Fibrotic Scar in the Comparison of Age-Related Macular Degeneration Treatments Trials
Avni P. Finn, Maxwell Pistilli, Vincent Tai, Ebenezer Daniel, Gui‐Shuang Ying, Maureen G. Maguire, Juan E. Grunwald, Daniel Francis Martin, Glenn J. Jaffe, Cynthia Ann Toth · 2020 · American Journal of Ophthalmology
Antivascular endothelial growth factor agents for wet age-related macular degeneration: an IRIS registry analysis
Mathew W. MacCumber, Justin S. Yu, Alexandros Sagkriotis, B Guruprasad, Bhavya Burugapalli, Xiaoyu Bi, Neetu Agashivala, Charles C. Wykoff · 2021 · Canadian Journal of Ophthalmology
SAFETY AND THERAPEUTIC EFFECTS OF ORALLY ADMINISTERED AKST4290 IN NEWLY DIAGNOSED NEOVASCULAR AGE-RELATED MACULAR DEGENERATION
Michael W. Stewart, Seema Garg, Erin Newman, Elizabeth Jeffords, Joanna Konopińska, Sam Jackson, Bartosz L. Sikorski, Esther Rawner · 2022 · Retina
CONVERSION TO AFLIBERCEPT THERAPY VERSUS CONTINUING WITH RANIBIZUMAB THERAPY FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION DEPENDENT ON MONTHLY RANIBIZUMAB TREATMENT
Irmela Mantel, Christina Gianniou, Ali Dirani · 2015 · Retina
Comparative safety profiles of intravitreal bevacizumab, ranibizumab and pegaptanib: the analysis of the WHO database of adverse drug reactions
Carlotta Biagi, Valentino Conti, Nicola Montanaro, Mauro Melis, Elena Buccellato, M. Donati, Anna Covezzoli, R. Amato, L. Pazzi, Mauro Venegoni et al. · 2014 · European Journal of Clinical Pharmacology
Comparison of 1-year therapeutic effect of ranibizumab and bevacizumab for myopic choroidal neovascularization: a retrospective, multicenter, comparative study
Dong Min Cha, Tae Wan Kim, Jang Won Heo, Se Joon Woo, Kyu Hyung Park, Hyeong Gon Yu, Hum Chung · 2014 · BMC Ophthalmology
Combined Depth Imaging Technique on Spectral-Domain Optical Coherence Tomography
Giulio Barteselli, Dirk‐Uwe Bartsch, Sharif El-Emam, Maria Laura Gomez, Jay Kumar Chhablani, Su Na Lee, Laura Conner, William R. Freeman · 2012 · American Journal of Ophthalmology
Potential penetration of topical ranibizumab (Lucentis) in the rabbit eye
J J Chen, S E Ebmeier, W M Sutherland, Nicola G. Ghazi · 2011 · Eye
Assessment of Differential Pharmacodynamic Effects Using Optical Coherence Tomography in Neovascular Age-Related Macular Degeneration
Pearse Andrew Keane, Florian M. Heussen, Yanling Ouyang, Nils Mokwa, Alexander C. Walsh, Adnan Tufail, Srinivas Reddy Sadda, Praveen J. Patel · 2012 · Investigative Ophthalmology & Visual Science
Ranibizumab injection for diabetic macular edema: meta-analysis of systemic safety and systematic review
Marwan A. Abouammoh · 2013 · Canadian Journal of Ophthalmology
Treatments for macular oedema following central retinal vein occlusion: systematic review
John Alexander Ford, Christine Clar, Noemi Lois, Samantha Barton, Siân Thomas, Rachel A. Court, D Shyangdan, Norman R Waugh · 2014 · BMJ Open
Autophagy Regulating Kinases As Potential Therapeutic Targets For Age-Related Macular Degeneration
Kai Kaarniranta, Anu Kauppinen, Janusz Błasiak, Antero Salminen · 2012 · Future Medicinal Chemistry
Treatment as Required versus Regular Monthly Treatment in the Management of Neovascular Age-Related Macular Degeneration: A Systematic Review and Meta-Analysis
Christine M. Schmucker, Gerta Rücker, Harriet Sommer, Gianni Virgili, Yoon Kong Loke, Patrick Oeller, Hansjuergen Agostini, Christoph Ehlken · 2015 · PLoS ONE
Real world evidence of use of anti-VEGF therapy in Denmark
Henrik Vorum, Thorbjørn Kruse Olesen, Jette Zinck, Morten Størling Hedegaard · 2016 · Current Medical Research and Opinion
The fate of eyes with wet AMD beyond four years of anti-VEGF therapy
Justus Gerhard Garweg, Johanna J. Zirpel, Christin Gerhardt, Isabel B. Pfister · 2018 · Graefe s Archive for Clinical and Experimental Ophthalmology
Hydrodynamics of Intravitreal Injections into Liquid Vitreous Substitutes
Christin Henein, Sahar Awwad, Nkiruka Ibeanu, Stavros Vlatakis, Steve Brocchini, Peng Tee Khaw, Yann Bouremel · 2019 · Pharmaceutics
Treatment Outcomes of Ranibizumab versus Aflibercept for Neovascular Age-Related Macular Degeneration
Sanjeeb Bhandari, Vuong Nguyen, Jennifer Arnold, Stephanie H. Young, Gayatri Banerjee, Mark C. Gillies, Daniel Barthelmes · 2019 · Ophthalmology
Intravitreal aflibercept for submacular hemorrhage secondary to neovascular age-related macular degeneration and polypoidal choroidal vasculopathy
Jae Hui Kim, Chul Gu Kim, Dong Won Lee, Su Jin Yoo, Young Ju Lew, Han Joo Cho, Joo Yeon Kim, Seok Hyun Lee, Jong Woo Kim · 2019 · Graefe s Archive for Clinical and Experimental Ophthalmology
Incidence of Glaucoma or Ocular Hypertension After Repeated Anti-Vascular Endothelial Growth Factor Injections for Macular Degeneration
Jeremy B. Wingard, Darcie A. P. Delzell, Nathan V. Houlihan, Jonathan Lin, Jon P. Gieser · 2019 · Clinical ophthalmology
Quantification, Microbial Contamination, Physico-chemical Stability of Repackaged Bevacizumab Stored Under Different Conditions
Leonarda Signorello, Stefania Pucciarelli, Giulia Bonacucina, Valeria Polzonetti, Marco Cespi, Diego Romano Perinelli, Giovanni Filippo Palmieri, Riccardo Pettinari, Claudio Pettinari, Giovanni Fiorentini et al. · 2014 · Current Pharmaceutical Biotechnology
Initiation and maintenance of a Treat-and-Extend regimen for ranibizumab therapy in wet age-related macular degeneration: recommendations from the UK Retinal Outcomes Group
Winfried M. K. Amoaku, Konstantinos Balaskas, Tomas Cudrnak, Louise Downey, Markus Groppe, Sajjad Mahmood, Hemal Mehta, Quresh Amir Mohamed, Bushra Mushtaq, Philip S. Severn et al. · 2018 · Clinical ophthalmology
Current best clinical practices—management of neovascular AMD
Brown, David, Heier, Jeffrey S., Boyer, David S., Freund, K. Bailey, Kaiser, Peter, Kim, Judy E., Sarraf, David · 2017 · Journal of VitreoRetinal Diseases
Efficacy οf Wet Age‐related Macular Degeneration Treatment οn Reading: A Pilot Study Using Eye‐movement Analysis
Emmanouil Ktistakis, Panagiotis G. Simos, Miltiadis K. Tsilimbaris, Sotiris Plainis · 2023 · Optometry and Vision Science
Initial Functional and Anatomical Outcomes of High-dose Aflibercept 8 mg in Exudative Neovascular Age-related Macular Degeneration
Suraj Bala, Gabriel Castilho Sandoval Barbosa, Nitesh Mohan, Sunil K. Srivastava, Peter K. Kaiser, Ananth Sastry, Amy S Babiuch, Jonathan E. Sears, Katherine E. Talcott, Alex Yuan et al. · 2025 · Ophthalmology Retina
Angiogenesis and Vascular Endothelial Growth Factor-A Expression Associated with Inflammation in Pediatric Crohn’s Disease
Jennifer Leslie Knod, Kelly M. Crawford, Mary R. Dusing, Margaret H. Collins, Artur Chernoguz, Jason S. Frischer · 2015 · Journal of Gastrointestinal Surgery
Aflibercept for pigment epithelial detachment for previously treated neovascular age-related macular degeneration
James C. Major, Charles C. Wykoff, Daniel E. Croft, Rui Wang, Angeline F. Mariani, Anna E. Lehmann, David M. Brown · 2015 · Canadian Journal of Ophthalmology
RELATIONSHIP BETWEEN VISUAL PROGNOSIS AND DELAY OF INTRAVITREAL INJECTION OF RANIBIZUMAB WHEN TREATING AGE-RELATED MACULAR DEGENERATION
Hidenori Takahashi, Yuko Ohkubo, Aya Sato, Mikiko Takezawa, Yujiro Fujino, Yasuo Yanagi, Hidetoshi Kawashima · 2015 · Retina
Systemic safety of anti-VEGF drugs: a commentary
Lauren J Scott, Usha Chakravarthy, Barnaby C Reeves, Chris A. Rogers · 2014 · Expert Opinion on Drug Safety
Optical coherence tomographic and visual results at six months after transitioning to aflibercept for patients on prior ranibizumab or bevacizumab treatment for exudative age-related macular degeneration (an American Ophthalmological Society thesis).
Clement K. Chan, Atul Jain, Srinivas Reddy Sadda, Neeta Varshney · 2014 · Europe PMC (PubMed Central)
Effects of bevacizumab in retina and choroid after intravitreal injection into monkey eyes
Ulrich Schraermeyer, Sylvie Julien · 2012 · Expert Opinion on Biological Therapy
Ophthalmology 3 Corneal transplantation
Donald T.H. Tan, John K.G. Dart, Edward J. Holland, Shigeru Kinoshita · 2012 · UCL Discovery (University College London)
OUTCOMES OF PATIENTS WITH EXUDATIVE AGE-RELATED MACULAR DEGENERATION TREATED WITH ANTIVASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY FOR THREE OR MORE YEARS
Vivian L. Qin, Jason Young, Fabiana Queiroga de Paula Araujo Silva, Felipe F. Conti, Rishi P. Singh · 2017 · Retina
Improving Biopharmaceutical Safety Through Verification‐Based Quality Control
Yu, Yihua Bruce, Taraban, Marc B., Wang, Weizhen, Briggs, Katharine T. · 2017 · Trends in Biotechnology
RESIDUAL CHOROIDAL VESSELS IN ATROPHY CAN MASQUERADE AS CHOROIDAL NEOVASCULARIZATION ON OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY
Peter L. Nesper, Gerard A. Lutty, Amani A. Fawzi · 2017 · Retina
Intravitreal aflibercept compared with panretinal photocoagulation for proliferative diabetic retinopathy: the CLARITY non-inferiority RCT
Sobha Sivaprasad, Philip G. Hykin, Andrew Toby Prevost, Joana Carvalho Vasconcelos, Amy Riddell, Jayashree Ramu, Caroline Murphy, Joanna Kelly, Rhiannon Tudor Edwards, Seow Tien Yeo et al. · 2018 · Efficacy and Mechanism Evaluation
GEOGRAPHIC ATROPHY INCIDENCE AND PROGRESSION AFTER INTRAVITREAL INJECTIONS OF ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR AGENTS FOR AGE-RELATED MACULAR DEGENERATION
Arshia Eshtiaghi, Mariam Issa, Marko M. Popovic, Rajeev H. Muni, Peter J. Kertes · 2021 · Retina
The Effect of Treatment Discontinuation During the COVID-19 Pandemic on Visual Acuity in Exudative Neovascular Age-Related Macular Degeneration: 1-Year Results
Martin Stattin, Daniel Ahmed, Alexandra Christine Graf, Anna‐Maria Haas, Stefan Kickinger, Michael Jacob, Katharina Krepler, Siamak Ansari‐Shahrezaei · 2021 · Ophthalmology and Therapy
Acute Anterior Uveitis Following Intravitreal Injection of Bevacizumab
Mozayan, Arash, Farah, Samer · 2013 · Ophthalmic Surgery, Lasers and Imaging Retina